NCT00335777View on ClinicalTrials.gov

A Research Study Examining Migranal and Skin Sensitivity in Subjects With Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2009

Conditions
Migraine
Interventions
DRUG

Migranal nasal spray at 1 hour

Migranal® 4 mg. will be self administered by each subject in the following manner: one spray in each nostril, wait 15 minutes then follow with one spray in each nostril. This will deliver the desired 4 mg. dose.

DRUG

Migranal nasal spray at 4 hour

Migranal® 4 mg. will be self administered by each subject in the following manner: one spray in each nostril, wait 15 minutes then follow with one spray in each nostril. This will deliver the desired 4 mg. dose.

Trial Locations (1)

19107

Jefferson Headache Center, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT00335777 - A Research Study Examining Migranal and Skin Sensitivity in Subjects With Migraine | Biotech Hunter | Biotech Hunter